These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinicopathological aspects of Chediak-Higashi syndrome in the accelerated phase. Shome DK; Al-Mukharraq H; Mahdi N; Ameen G; Farid E Saudi Med J; 2002 Apr; 23(4):464-6. PubMed ID: 11953777 [TBL] [Abstract][Full Text] [Related]
6. In patients with Chediak-Higashi syndrome undergoing allogeneic SCT, does adding etoposide to the conditioning regimen improve the outcome? Ayas M; Al-Ghonaium A Bone Marrow Transplant; 2007 Sep; 40(6):603. PubMed ID: 17637689 [No Abstract] [Full Text] [Related]
7. Genetic analysis in Egyptian patients with Chediak-Higashi syndrome reveals new LYST mutations. Gomaa NS; Lee JYW; El Sharkawy A; El Chazli YF; Hassab HMA; Doghaim NN; McGrath JA; Onoufriadis A Clin Exp Dermatol; 2019 Oct; 44(7):814-817. PubMed ID: 30815890 [No Abstract] [Full Text] [Related]
8. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome. Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan. Nagai K; Ochi F; Terui K; Maeda M; Ohga S; Kanegane H; Kitoh T; Kogawa K; Suzuki N; Ohta S; Ishida Y; Okamura T; Wakiguchi H; Yasukawa M; Ishii E Pediatr Blood Cancer; 2013 Oct; 60(10):1582-6. PubMed ID: 23804531 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation in a patient with Chédiak-Higashi Syndrome. Griscelli C; Virelizier JL Birth Defects Orig Artic Ser; 1983; 19(3):333-4. PubMed ID: 6360244 [No Abstract] [Full Text] [Related]
14. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Haddad E; Le Deist F; Blanche S; Benkerrou M; Rohrlich P; Vilmer E; Griscelli C; Fischer A Blood; 1995 Jun; 85(11):3328-33. PubMed ID: 7756666 [TBL] [Abstract][Full Text] [Related]
15. Rapid ultrastructural detection of success or failure after bone marrow transplantation in the Chediak-Higashi syndrome. White JG; Hess RA; Gahl WA; Introne W Platelets; 2013; 24(1):71-4. PubMed ID: 22738378 [TBL] [Abstract][Full Text] [Related]
16. The role of high dose methylprednisolone and splenectomy in the accelerated phase of Chédiak-Higashi syndrome. Aslan Y; Erduran E; Gedik Y; Mocan H; Yildiran A Acta Haematol; 1996; 96(2):105-7. PubMed ID: 8701696 [TBL] [Abstract][Full Text] [Related]
17. A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase. Wu XL; Zhao XQ; Zhang BX; Xuan F; Guo HM; Ma FT Braz J Med Biol Res; 2017 Mar; 50(4):e5727. PubMed ID: 28355352 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation in Chédiak-Higashi syndrome. Möttönen M; Lanning M; Saarinen UM Pediatr Hematol Oncol; 1995; 12(1):55-9. PubMed ID: 7703042 [TBL] [Abstract][Full Text] [Related]
19. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Tardieu M; Lacroix C; Neven B; Bordigoni P; de Saint Basile G; Blanche S; Fischer A Blood; 2005 Jul; 106(1):40-2. PubMed ID: 15790783 [TBL] [Abstract][Full Text] [Related]